Altered expression of the cyclin E protein was reported in most breast tumour tissues and leukemia solid tumours examined to date, and aberrant levels increase with increases in tumour grade and stage [36], [71], which makes it a potential prognostic marker for some tumours. This evidence concerns the gene CCNE1 and breast neoplasm.